2026-01-08T00:00:00.000+11:00
Ongoing

DASL-HiCAP ANZUP1801

DASL-HiCAP ANZUP1801
Prostate

DASL-HiCAP ANZUP1801: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801): A Randomised Phase 3 Double-blind, Placebo-controlled Trial of Adding Darolutamide to Androgen Deprivation Therapy and Definitive or Salvage Radiation in Very High Risk, Clinically Localised Prostate Cancer

DASL-HiCAP ANZUP1801: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801)

Trial overview

Clinical Area

Radiation Oncology

Disease

Prostate

Disease site

Genitourinary (GU)

Study Phase

Phase III

Trial Identifiers

Registration number: NCT04136353

https://clinicaltrials.gov/study/NCT04136353

GenesisCare Location(s)
Principal Investigator(s)
Radiation Oncologist

Prof Jarad Martin

MBChB BSc PhD DMed, FRANZCR GAustMS

Prof Jarad Martin
Jarad
Martin
View Profile
Profile Image - Prof Jarad Martin

Clinical trials enquiries

Thank you for submitting.

Thank you for submitting.

We will be in touch within 24 hours

Form submission error

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

 

* Indicates a required field.

 

The flag of Australia has a dark blue field. It features the flag of the United Kingdom — the Union Jack — in the canton, beneath which is a large white seven-pointed star. A representation of the Southern Cross constellation, made up of one small five-pointed and four larger seven-pointed white stars, is situated on the fly side of the field. dropdown icon
search icon
    +61
    dropdown icon
    • ACT
    • NSW
    • NT
    • QLD
    • VIC
    • SA
    • TAS
    • WA

    Please refer to your hospitals process for inpatient referrals...

    Find a centre